InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Richard Ding, 董事. Director active across 1 company, notably Moberg Pharma AB (publ). Aggregated, 8 filings have been recorded. Activity tracked since 23 June 2025. The latest transaction was disclosed on 18 August 2026 (Sale). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Richard Ding is a board member of Moberg Pharma AB (publ), a company specializing in the development of pharmaceutical products. As a board member, he contributes to the oversight of operations and the strategic direction of the company. Richard brings valuable expertise in the pharmaceutical sector, which is essential for the development of innovative solutions. His commitment to operational excellence is an asset for Moberg Pharma.